C0001163629T1
The Global Head of Commercial Biosimilars leads the commercial success of the biosimilar portfolio, defining and executing the commercial vision, strategy, and go-to-market models for key markets like the US and Europe. This role involves driving launch excellence, guiding access and pricing strategies, and evolving commercial capabilities to maximize business outcomes. The position requires inspiring high-performing teams and contributing to the Global Biosimilars Leadership Team's overall portfolio strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for C0001163629T1.
C0001163629T1 didn’t post a salary, so this is our estimate from similar listings.